Johnson & Johnson tops forecasts

johnson & johnsonJohnson & Johnson has reported a net income of $US4 billion ($A5.26 billion) for the second quarter.

The results surpassed Wall Street expectations.

The world’s biggest maker of healthcare products posted revenue of $US18.48 billion in the period, topping Street forecasts. Five analysts surveyed by Zacks Investment Research expected $US17.89 billion.

Johnson & Johnson shares have increased 20 per cent since the beginning of the year, while the Standard & Poor’s 500 index has increased 6 per cent. The stock has risen 22 per cent in the last 12 months.


Comment Manually

I have read and agree to the Terms and Conditions and Privacy Policy.

Inside FMCG Jobs


FMCG Products



View details

Latest Poll

Do you think the Health Star Rating should be axed?

FREE NEWS BRIEFS Get breaking news delivered